510(k) K992851
K992851 is an FDA 510(k) premarket notification submitted by Roche Diagnostics Corp. for the device "ACT TEST CATRIDGES FOR COAGUCHEK PRO SYSTEM, ACT CONTROLS FOR COAGUCHEK PRO SYSTEM". The FDA issued a decision of Substantially Equivalent on January 14, 2000. The device falls under product code JBP (Activated Whole Blood Clotting Time), a Class II device regulated under 21 CFR 864.7140. Roche Diagnostics Corp. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- January 14, 2000
- Date Received
- August 24, 1999
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Activated Whole Blood Clotting Time
- Device Class
- Class II
- Regulation Number
- 864.7140
- Review Panel
- HE
- Submission Type